Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01858389
Title A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Tower Hematology Oncology Medical Group Beverly Hills California 90211 United States Details
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 United States Details
Georgetown University Hospital-Lombardi Comprehensive Cancer Center Washington, D.C. District of Columbia 20007 United States Details
Georgetown University Medical Center Department of Pharmacy, Research Washington, D.C. District of Columbia 20007 United States Details
Memorial Sloan-Kettering Cancer Center-Rockefeller Outpatient Pavilion New York New York 10022 United States Details
Investigational Drug Service, Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
UT Southwestern Medical Center-Simmons Cancer Center Pharmacy Dallas Texas 75390-9015 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
UT Southwestern University Hospital - William P. Clements, Jr. Dallas Texas 75390 United States Details
UT Southwestern University Hospital - Zale Lipshy Dallas Texas 75390 United States Details
Severance Hospital, Yonsei University Health System Seoul 120-752 Korea, Republic of Details
Samsung Medical Center Seoul 135-710 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field